1. Home
  2. POCI vs PHGE Comparison

POCI vs PHGE Comparison

Compare POCI & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POCI
  • PHGE
  • Stock Information
  • Founded
  • POCI 1982
  • PHGE 2015
  • Country
  • POCI United States
  • PHGE Israel
  • Employees
  • POCI N/A
  • PHGE N/A
  • Industry
  • POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • POCI Health Care
  • PHGE Health Care
  • Exchange
  • POCI Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • POCI 27.2M
  • PHGE 26.5M
  • IPO Year
  • POCI N/A
  • PHGE N/A
  • Fundamental
  • Price
  • POCI $5.23
  • PHGE $0.68
  • Analyst Decision
  • POCI
  • PHGE Strong Buy
  • Analyst Count
  • POCI 0
  • PHGE 2
  • Target Price
  • POCI N/A
  • PHGE $22.50
  • AVG Volume (30 Days)
  • POCI 16.0K
  • PHGE 155.5K
  • Earning Date
  • POCI 11-14-2024
  • PHGE 11-14-2024
  • Dividend Yield
  • POCI N/A
  • PHGE N/A
  • EPS Growth
  • POCI N/A
  • PHGE N/A
  • EPS
  • POCI N/A
  • PHGE N/A
  • Revenue
  • POCI $18,980,148.00
  • PHGE N/A
  • Revenue This Year
  • POCI N/A
  • PHGE N/A
  • Revenue Next Year
  • POCI N/A
  • PHGE N/A
  • P/E Ratio
  • POCI N/A
  • PHGE N/A
  • Revenue Growth
  • POCI N/A
  • PHGE N/A
  • 52 Week Low
  • POCI $3.47
  • PHGE $0.61
  • 52 Week High
  • POCI $6.90
  • PHGE $8.55
  • Technical
  • Relative Strength Index (RSI)
  • POCI 63.01
  • PHGE 36.17
  • Support Level
  • POCI $4.38
  • PHGE $0.67
  • Resistance Level
  • POCI $5.35
  • PHGE $0.79
  • Average True Range (ATR)
  • POCI 0.42
  • PHGE 0.09
  • MACD
  • POCI 0.14
  • PHGE 0.01
  • Stochastic Oscillator
  • POCI 93.62
  • PHGE 42.21

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

Share on Social Networks: